These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis. Sahara K, Tsilimigras DI, Mehta R, Moro A, Paredes AZ, Lopez-Aguiar AG, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Poultsides GA, Makris E, Cho C, Beems M, Dillhoff M, Maithel SK, Endo I, Pawlik TM. Ann Surg Oncol; 2020 Apr; 27(4):1203-1212. PubMed ID: 31838609 [Abstract] [Full Text] [Related]
11. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article. Li G, Tian ML, Bing YT, Tao LY, Wang HY, Jiang B, Yuan CH, Xiu DR. Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623 [Abstract] [Full Text] [Related]
12. A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors. Gaitanidis A, Patel D, Nilubol N, Tirosh A, Kebebew E. J Clin Endocrinol Metab; 2018 Jan 01; 103(1):187-195. PubMed ID: 29069375 [Abstract] [Full Text] [Related]
13. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. Gratian L, Pura J, Dinan M, Roman S, Reed S, Sosa JA. Ann Surg Oncol; 2014 Oct 01; 21(11):3515-21. PubMed ID: 24841347 [Abstract] [Full Text] [Related]
14. Significance of lymph node metastasis in pancreatic neuroendocrine tumor. Taki K, Hashimoto D, Nakagawa S, Ozaki N, Tomiyasu S, Ohmuraya M, Arima K, Kaida T, Higashi T, Sakamoto K, Sakata K, Okabe H, Nitta H, Hayashi H, Chikamoto A, Beppu T, Takamori H, Hirota M, Baba H. Surg Today; 2017 Sep 01; 47(9):1104-1110. PubMed ID: 28229300 [Abstract] [Full Text] [Related]
16. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database. Mao R, Zhao H, Li K, Luo S, Turner M, Cai JQ, Blazer D. Ann Surg Oncol; 2019 Sep 01; 26(9):2722-2729. PubMed ID: 31209670 [Abstract] [Full Text] [Related]
17. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production. Tsutsumi K, Ohtsuka T, Mori Y, Fujino M, Yasui T, Aishima S, Takahata S, Nakamura M, Ito T, Tanaka M. J Gastroenterol; 2012 Jun 01; 47(6):678-85. PubMed ID: 22350698 [Abstract] [Full Text] [Related]
18. Regional Metastatic Behavior of Nonfunctional Pancreatic Neuroendocrine Tumors: Impact of Lymph Node Positivity on Survival. Jutric Z, Grendar J, Hoen HM, Cho SW, Cassera MA, Newell PH, Hammill CW, Hansen PD, Wolf RF. Pancreas; 2017 Aug 01; 46(7):898-903. PubMed ID: 28697130 [Abstract] [Full Text] [Related]
19. Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems. Benetatos N, Hodson J, Marudanayagam R, Sutcliffe RP, Isaac JR, Ayuk J, Shah T, Roberts KJ. Hepatobiliary Pancreat Dis Int; 2018 Apr 01; 17(2):169-175. PubMed ID: 29576279 [Abstract] [Full Text] [Related]
20. Predictors of lymph node metastasis and survival in radically resected rectal neuroendocrine tumors: A Surveillance, Epidemiology, and End Results (SEER) database analysis. Emile SH, Horesh N, Garoufalia Z, Gefen R, Wignakumar A, Wexner SD. Surgery; 2024 Sep 01; 176(3):668-675. PubMed ID: 38918107 [Abstract] [Full Text] [Related] Page: [Next] [New Search]